image de fond
REACH Authorisation
made simple
go to  the twitter account go to  the linkedin account


The Priority List of substances requiring Authorisation for continued use is growing and it is essential that companies are well prepared. Authorisation could have a significant impact on businesses and many companies may be affected, either as producers or users of identified "Substances of Very High Concern" (SVHCs).

Nickel Institute has drawn on its wide experience of the REACH Regulation to produce this guide to the REACH Authorisation process. REACH Authorisation made simple aims to assist those people who are responsible for initiating and managing preparation for Authorisation within their company and help unravel the process in such a way that it can be explained to non-specialists.

We know that communication within the value chain can be tremendously challenging and many of those who have a key role in the process are often far from familiar with REACH, let alone Authorisation.

Based on the extensive exploratory work performed by the Nickel Institute and the lessons learned from the first listings for Authorisation, this guide:
  • Describes the Authorisation process step-by-step
  • Identifies the relevant stakeholders at each stage of the process
  • Clarifies the role of stakeholders
  • Indicates when business and technical decisions have to be taken
  • Provides guidance on the DOs and DON’Ts
  • Flags potential legal issues where specialist advice may be needed

Nickel Institute is pleased to share its experience through this guide and we hope it will help smooth the way for anyone feeling daunted by the prospect of managing the REACH Authorisation process within their organisation.

The materials and information included in this publication are provided
as a service to you and do not necessarily reflect endorsement by the
Nickel Institute. The Nickel Institute is not responsible for the accuracy
of information provided from outside sources.
Users are advised to seek their own professional advice.